HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma. Issue 1 (February 2020) - Stevens, Wendy B.C.
Abstract : Supplemental Digital Content is available in the text